[{"NetIncomeLoss_2_Q2_USD":-11083000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6067000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3460000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":46896081.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":46896280.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":2921000.0,"LimitedLiabilityCompanyLLCPreferredUnitAuthorized_0_Q2_shares":32620000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-235000.0,"DebtInstrumentInterestRateDuringPeriod_2_Q2_pure":0.2056,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2292309.0,"StockholdersEquityNoteStockSplitConversionRatio1_2_Q2_pure":1.0,"AccruedSalariesCurrentAndNoncurrent_0_Q2_USD":1222000.0,"AssetsCurrent_0_Q2_USD":69479000.0,"LongTermDebt_0_Q2_USD":0.0,"LongTermDebtCurrent_0_Q2_USD":3884000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":385000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":39070565.0,"ReceivablesLongTermContractsOrPrograms_0_Q2_USD":0.0,"DueToRelatedPartiesCurrent_0_Q2_USD":883000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":353000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":0.0,"Assets_0_Q2_USD":77321000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":735000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":2921000.0,"PreferredStockSharesOutstanding_0_Q2_shares":27629804.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":1720000.0,"LimitedLiabilityCompanyLLCPreferredUnitOutstanding_0_Q2_shares":27629804.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3759000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.99,"AccruedProfessionalFeesCurrentAndNoncurrent_0_Q2_USD":348000.0,"MembersCapital_0_Q2_USD":1412000.0,"PrepaidExpenseCurrent_0_Q2_USD":165000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1554000.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":27888611.0,"FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_2_Q2_USD":11100000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":44000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-2717000.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":1885000.0,"CommonUnitOutstanding_0_Q2_shares":46896280.0,"DepreciationDepletionAndAmortization_2_Q2_USD":264000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-0.0017,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.0021,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":6167000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":606000.0,"LimitedLiabilityCompanyLLCPreferredUnitIssued_0_Q2_shares":27629804.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":286000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":70000.0,"CommonUnitAuthorized_0_Q2_shares":101000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":69314000.0,"Liabilities_0_Q2_USD":9961000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":2292309.0,"DeferredCosts_0_Q2_USD":3412000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":38738611.0,"ResearchAndDevelopmentExpense_2_Q2_USD":7106000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":1779000.0,"DeferredRevenue_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-3744000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":0.0,"InterestPaid_2_Q2_USD":170000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":124000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":1350000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-11039000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-5484000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":282000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_2_Q2_USD":738000.0,"PreferredStockLiquidationPreferenceValue_0_Q2_USD":202264000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-9676000.0,"ProceedsFromWarrantExercises_2_Q2_USD":13000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-125086000.0,"LiabilitiesCurrent_0_Q2_USD":9355000.0,"AccountsPayableCurrent_0_Q2_USD":1667000.0,"InterestExpense_2_Q2_USD":357000.0,"InterestExpense_1_Q2_USD":169000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":69300000.0,"LongTermDebtNoncurrent_0_Q2_USD":0.0,"PartnersCapital_0_Q2_USD":-123674000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":69314000.0,"MembersEquity_0_Q2_USD":-123674000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":1125000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4430000.0,"NetIncomeLoss_1_Q2_USD":-5485000.0,"DeferredRevenueCurrent_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2292309.0,"AccountsReceivableRelatedParties_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":421000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2717000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1961000.0,"OperatingIncomeLoss_2_Q2_USD":-10456000.0,"OperatingIncomeLoss_1_Q2_USD":-5258000.0,"PreferredUnitsPreferredPartnersCapitalAccounts_0_Q2_USD":191034000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":73700000.0,"InvestmentIncomeInterest_2_Q2_USD":60000.0,"InvestmentIncomeInterest_1_Q2_USD":13000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.99,"PreferredStockValue_0_Q2_USD":191034000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":77321000.0,"PreferredStockSharesAuthorized_0_Q2_shares":32620000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":282000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":282000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":14500000.0,"DeferredRevenueAdditions_2_Q2_USD":0.0,"OperatingExpenses_2_Q2_USD":13173000.0,"OperatingExpenses_1_Q2_USD":7219000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.24,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.12,"ProfitLoss_2_Q2_USD":-11083000.0,"DeferredOfferingCosts_0_Q2_USD":3400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":235000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":4254000.0,"CommonUnitIssued_0_Q2_shares":46896280.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":4.99,"ProceedsFromIssuanceOfPreferredLimitedPartnersUnits_2_Q2_USD":6320000.0,"Ticker":"RANI","CIK":"1856725","name":"RANI THERAPEUTICS HOLDINGS, INC.","OfficialName":"Rani Therapeutics Holdings Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"347515178.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210913"}]